Explained How mRNA vaccine is different

India has approved nine COVID-19 vaccines up until now, of which three - Serum Institute of India's Covishield, Bharat Biotech's Covaxin and Russian vaccine Sputnik V - are being administered in India to people who fit the eligibility criteria.

In October 2021, the country crossed the one billion mark for administered vaccine doses. As of now, about 76 percent of adults have been fully vaccinated, while more than 99 percent have so far received their first dose.

This year, since January 10, India began administering 'precaution dose' to healthcare and frontline workers along with those aged 60 and above.

Now with the Omicron variant in circulation, India is set to launch its first ever 'homegrown' mRNA COVID vaccine, which scientists believe may be effective against the Omicron too. That said, let us find out what makes it different from the other COVID vaccines in use in India.

Also read: Coronavirus: 8 sure-shot symptoms of Omicron; know when you're likely to get them

Bagikan Artikel ini